# Gentherm Inc: Form 10-Q for the period ended Mar 31, 2014

- Company: [Gentherm Inc](/companies/thrm.md) (CIK 903129)
- Form: 10-Q
- Filed: 2014-05-09
- Accepted by EDGAR: May 9, 2014, 11:10 ET
- Period: 2014-03-31
- Accession: 0001564590-14-001983
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/903129/000156459014001983/thrm-10q_20140331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/903129/000156459014001983/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-01-01 to 2014-03-31 | $193.9m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2014-01-01 to 2014-03-31 | $136.9m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2014-01-01 to 2014-03-31 | $57.0m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2014-01-01 to 2014-03-31 | $18.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-01-01 to 2014-03-31 | $24.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2014-01-01 to 2014-03-31 | $6.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-01-01 to 2014-03-31 | $16.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-01-01 to 2014-03-31 | $0.47 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-01-01 to 2014-03-31 | $0.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-01-01 to 2014-03-31 | 35,592,026 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2014-01-01 to 2014-03-31 | −$3.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2014-01-01 to 2014-03-31 | $6.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2014-03-31 | $57.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-03-31 | $301.0m | us-gaap:AssetsCurrent |
| Total assets | at 2014-03-31 | $513.3m | us-gaap:Assets |
| Current liabilities | at 2014-03-31 | $156.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-03-31 | $261.8m | us-gaap:Liabilities |
| Long-term debt | at 2014-03-31 | $69.8m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2014-03-31 | $251.6m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Management's discussion and analysis

As filed, 16,167 characters.

### FORWARD LOOKING STATEMENTS

*This Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Reference is made in particular to the description of our plans and objectives for future operations, assumptions underlying such plans and objectives and other forward-looking statements included in “Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and in other places in this Report. Such statements may be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” or similar terms, variations of such terms or the negative of such terms. The forward-looking statements included in this Report are made as of the date hereof and are based on management’s current expectations and beliefs. Such statements are subject to a number of factors and uncertainties, which are set forth below and elsewhere in this Report that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.*

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our financial statements and related notes thereto included elsewhere in this report and in our Annual Report on Form 10-K for the year ended December 31, 2013.

### General

Gentherm is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies and cable systems. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and identify future climatic comfort product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies that will improve overall product effectiveness and customer satisfaction. New design applications of our existing technologies help us to create new product and market opportunities for thermal comfort solutions.

We operate as a Tier II supplier to the auto industry. Inherent in this market are costs and commitments well in advance of the receipt of orders (and resulting revenues) from customers. This is due in part to automotive manufacturers requiring the design, coordination and testing of proposed new components and systems. Revenues from these expenditures may not be realized for two to three years as the manufacturers tend to group new components and enhancements into annual or every two to three year vehicle model introductions. These customers in turn sell our product, as a component of an entire seat or seating system, to automotive original equipment manufacturers (“OEMs”).

As part of the initiative to integrate the operations of historical Gentherm and W.E.T., changes were made to Gentherm’s structure of internal organization. The financial information used by our chief operating decision maker to assess performance and allocate resources reflects the changes brought about through this initiative. See Note 4 to the consolidated condensed financial statements included herein for a further description of our reportable segments, including segment information about the reported product revenues and operating income of the Company for the three-month periods ended March 31, 2014 and 2013.

We internally manufacture a large portion of our products at our production facilities. Other products we sell are manufactured by third parties. Our primary manufacturing locations are in Mexico, China and the Ukraine, all countries that have historically experienced a heightened degree of political, civil and labor uncertainty. Recent demonstrations and related violence in the Ukraine in particular highlight this risk to our manufacturing process. Although our manufacturing facility in the Ukraine is located in the far eastern part of the country and approximately 700 miles by road from Kiev, and approximately the same distance from the activities along the border of Ukraine and Russia, we cannot be certain that similar demonstrations, unrest and international tensions will not affect our facility. Furthermore, most of our products manufactured in the Ukraine are shipped across the border from the Ukraine to Hungary for further delivery to our customers. If that border crossing were to be closed for any reason, we would essentially experience a loss of the use of our Ukraine facility, which would have a material adverse effect on our business. Approximately 24% of our revenues are derived from products manufactured at our Ukraine facility.

#### First Quarter 2014 Compared with First Quarter 2013

*Product Revenues.* Product revenues for the three months ended March 31, 2014 (“First Quarter 2014”) were $193,938,000 compared with product revenues of $148,090,000 for the three months ended March 31, 2013 (“First Quarter 2013”), an increase of $45,848,000, or 31%. Higher revenue was primarily driven by continued strong shipments of climate controlled seat systems (“CCS”). CCS revenue increased by approximately $26,000,000, or 46%, to approximately $81,900,000, during the First Quarter 2014. This increase was partially the result of new program launches since First Quarter 2013 and by strong production volumes and sales of the vehicles equipped with CCS systems, particularly vehicles in the luxury segment of the automotive market. Additionally, certain vehicles that have been redesigned since the First Quarter 2013 are experiencing very strong production and sales levels, including the General Motors full size SUV platform (“K2XX”) and the Jeep Grand Cherokee. The increase was also attributable to improvement in sales to our Japan based customers which had recovered from weaker sales during First Quarter 2013. This weakness had begun to improve during the second half of 2013. Our seat heater revenue also increased by approximately $16,000,000, or 25%, to approximately $80,900,000. This reflected market penetration on certain vehicle programs and also the strong production volumes on General Motors’ K2XX platform. We also have significant growth in our heated steering wheel heater product which showed an increase of approximately $3,200,000, or 58%, to approximately $8,800,000. Our European based sales were significantly higher than the prior year as local economies and car sales in that region continue to improve. Foreign currency translation of our Euro denominated product revenue for First Quarter 2014, which was approximately €39,065,000 versus €34,900,000 during First Quarter 2013, increased our product revenues by approximately $2,277,000 or 2%. The average US Dollar/Euro exchange rate for First Quarter 2014 was 1.3790 versus 1.3207 for First Quarter 2013.

*Cost of Sales.* Cost of sales increased to $136,913,000 in First Quarter 2014 from $109,039,000 in First Quarter 2013. This increase of $27,874,000, or 26%, is due to increased sales volume partially offset by higher gross margin percentages. A favorable change in product mix, greater coverage of fixed costs at the higher volume levels, favorable contribution from our new electronics manufacturing facility in China and foreign currency impact on production expenses in the Mexican Peso (“MXN”) and Ukraine Hryvna (“UAH”) increased historical gross profit percentage during First Quarter 2014 to approximately 29% compared with 26% during First Quarter 2013. The favorable product mix is primarily attributable to the greater sales growth in CCS products on which we have historically had better margin performance. We launched our new electronics manufacturing facility during the second quarter of 2013. This new facility has since been in the process of increasing production volumes by producing existing component products that had formerly been produced by outside suppliers. The First Quarter 2014 is the first reporting period where the savings from insourcing were larger than the additional overhead costs of the facility. We expect to capture further margin improvements as this manufacturing facility continues to increase production volumes. Our manufacturing plants are located in Ukraine, Mexico and China. As a result, our production labor costs are incurred in the local currency of each of those countries. During the First Quarter 2014, MXN and UAH decreased in value to the USD by 5% and 14%, respectively.

*Net Research and Development Expenses.* Net research and development expenses were $13,045,000 during First Quarter 2014 compared to $11,841,000 in First Quarter 2013, an increase of $1,204,000, or 10%. This increase is primarily driven by additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. New product development includes automotive heated and cool storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices and other potential products.

We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

*Acquisition Transaction Expenses.* During The First Quarter 2014, we incurred $1,075,000 in fees and expenses associated with the acquisition of Global Thermoelectric Inc. which was completed on April 1, 2014. During the First Quarter 2013, we incurred $1,163,000 in fees, legal and other expenses associated with the acquisition of W.E.T. shares. These fees included payments totaling $750,000 to the holders of our Series C Convertible Preferred Stock who waived certain equity offering participation rights allowing for the partial funding of W.E.T. shares with Gentherm common stock.

*Selling, General and Administrative Expenses.* Selling, general and administrative expenses increased to $18,089,000 in First Quarter 2014 from $16,256,000 in First Quarter 2013, an increase of $1,833,000, or 11%. This increase in expenses is due to higher general legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases. The additional employees are primarily related to establishing a new electronics production facility in Shenzhen, China, and increasing sales and marketing efforts aimed at supporting our current product development strategy.

*Income Tax Expense.* During First Quarter 2014, we recorded an income tax expense of $6,302,000 representing an effective tax rate of 27% on earnings before income tax of $22,881,000. Our effective tax rate was estimated based upon a forecast of our full year results. During the First Quarter 2013, we recorded an income tax expense of $795,000 representing an effective tax rate of 7% on earnings before income tax of $10,704,000. This amount included a one-time benefit resulting from the American Taxpayer Relief Act of 2012 (“the Act”) which was signed into law on January 2, 2013. The Act restored the research and development credit and certain exemption under the foreign income tax rules, retroactively to the beginning of 2012. As a result, we recognized approximately $1,300,000 in benefits associated with our 2012 tax year during First Quarter 2013. Had the Act been adopted during 2012, the benefit would have been recorded during that year and First Quarter 2013 effective tax rate would have been 20%. The effective tax rates for First Quarter 2014 and First Quarter 2013 were lower than the US Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

### Liquidity and Capital Resources

The Company has funded its financial needs primarily through cash flows from operating activities and equity and debt financings. Based on its current operating plan, management believes cash and cash equivalents at March 31, 2014, together with cash flows from operating activities, are sufficient to meet operating and capital expenditure needs, and to service debt, for the foreseeable future. However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and materially and adversely affect our results of operations and financial condition. In addition, it is likely that we will need to complete one or more equity or debt financings if we consummate any significant acquisitions. There can be no assurance that such capital will be available at all or on reasonable terms, which could materially and adversely affect our future operations and business strategy.

The following table represents our cash and cash equivalents and short-term investments which are available for our business operations:

*(In thousands)*

|  | March 31, 2014 | December 31, 2013 |
| --- | ---: | ---: |
| Cash and cash equivalents | $57,651 | $54,885 |

We manage our cash, cash equivalents and short-term investments in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. Cash and cash equivalents increased by $2,766,000 in First Quarter 2014. Cash used in operating activities during First Quarter 2014 was $3,156,000 and was attributable to net income of $16,579,000, plus non-cash adjustments. Non-cash adjustments included depreciation and amortization of $7,473,000, stock compensation of $870,000, and other items. Offsetting these positive operating activities was the net increase in net operating assets and liabilities of $22,780,000, including working capital items and gains on the revaluation of derivatives of $557,000.

As of March 31, 2014, working capital was $144,757,000 as compared to $116,786,000 at December 31, 2013, an increase of $27,971,000, or 24%. This increase was primarily related to increases in accounts receivable and prepaid expenses and other assets of $21,153,000 and $5,786,000, respectively, partially offset by decreases in inventory, deferred income tax assets and the current portion of long-term debt of $457,000, $1,804,000 and $873,000, respectively, and increases in accounts payable and accrued liabilities of $2,798,000 and $904,000, respectively. Accounts receivable increased primarily as a result of increases in product revenues and timing differences between when sales in 2014 were realized compared with sales realized during 2013. Gentherm had proportionally more sales in the March 2014 compared with December 2013. Working Capital was also affected by changes in currency exchange rates.

Cash used in investing activities was $7,353,000 during First Quarter 2014, reflecting the purchase of the remaining equity in a joint venture totaling $628,000 and purchases of property, plant and equipment totaling $6,769,000. Purchases of property and equipment for the period are primarily related to expansion of production capacity, as well as replacement of existing equipment.

Cash provided by financing activities was $10,297,000 during First Quarter 2014, reflecting borrowings against our US Revolving Note and proceeds from the exercise of common stock options of $1,634,000. These amounts were partially offset by repayments on our outstanding term notes totaling $6,965,000.

Gentherm, Inc. and our subsidiaries have outstanding credit agreements with a syndicate of banks led by Bank of America. See Note 5 to the consolidated condensed financial statements included herein for a further description of our credit agreements.

## Market risk

As filed, 9,250 characters.

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U.S. government, and in high-quality corporate issuers.

We are exposed to market risk from changes in foreign currency exchange rates and short term interest rates. Market risks for changes in interest rates relate primarily to our debt obligations under our Bank of America credit facilities. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from suppliers not denominated in the functional currency of an individual location, foreign plant operations, intercompany indebtedness and include exposures to the European Euro, Canadian Dollar, Hungarian Forint, Ukrainian Hryvnia, Mexican Peso, and Korean Won. The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from this risk by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. We record the ineffective portion of hedging instruments, if any, to other income (expense) in the consolidated condensed statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

In March 2008, W.E.T. entered into a 10 year currency related interest rate swap (“CRS”) having a notional value of €10,000,000 or $13,790,000 as of March 31, 2014, in order to offset the interest rate risk associated with a debt financing which was repaid prior our acquisition of W.E.T. Under this agreement W.E.T. received interest equal to the then six-month Euro Interbank Offered Rate (“EURIBOR”), 0.42% at March 31, 2014, plus 1.40% and pays interest equal to the six-month EURIBOR when the exchange rate between the European Euro (“EUR”) and the Swiss Franc (“CHF”), which was 1.22 at March 31, 2014, equals or exceeds 1.46 EUR to the CHF or pays interest equal to the six-month EURIBOR plus a premium when this exchange rate is less than 1.46. The premium is calculated as \[(1.46 – current EUR/CHF rate)/current EUR/CHF rate\] x 100.

In 2011, W.E.T. brought a lawsuit against UniCredit Bank AG (“UniCredit”), a past financial advisor, stemming from the recommendation to invest in the aforementioned CRS. On March 25, 2013, the Munich District Court in Munich, Germany ruled in favor of W.E.T., asserting that UniCredit violated its duty to properly advise W.E.T. with respect to the initial negative market value of the CRS and UniCredit’s inherent conflict of interest in recommending that W.E.T. invest in CRS. The Munich District Court ruled that UniCredit must (1) pay €144,000 to W.E.T. and (2) bear the costs of all future obligations under the CRS, which were €8,584,000 or $11,838,000 as of March 31, 2014, plus additional accrued liabilities for past due payments under the CRS of approximately €5,380,000, or $7,419,000 as of March 31, 2014. UniCredit has appealed the decision and an oral hearing has been scheduled for July 9, 2014. With the appeal pending, the Company cannot be certain that any portion of the award by the Munich District Court will be realized by W.E.T. See the derivatives table below for information about our future obligations under the CRS as of March 31, 2014 and 2013, respectively. The Company has entered into offsetting derivative contracts designed to limit the market risk of payments due under the CRS through the end of the CRS agreement, in 2018.

In July 2011, the Company entered into two interest rate swap contracts with two separate financial institutions and an interest rate cap agreement in order to hedge the exposure to variable market interest rates on the Company’s Bank of America credit facilities. The interest rate swap contracts qualified for and are designated as cash flow hedges. Swap gains and losses are reported in accumulated other comprehensive income and will be reclassified to earnings once the Company’s Bank of America credit facilities are repaid. Cap gains and losses are reported in foreign currency gains and losses on the consolidated condensed statements of income. Information on the interest rate swap contracts is as follows:

| Contract Type | Contract Term | (in thousands) Notional Value | Hedged Instruments | Fixed Rate | Variable Rate | Rate Cap |
| --- | --- | ---: | --- | ---: | --- | ---: |
| Swap | June 30, 2014 | $8,000 | US Term Note | 1.27% | 3 month LIBOR | — |
| Swap | June 30, 2014 | $8,000 | US Term Note | 1.27% | 3 month LIBOR | — |
| Cap | March 31, 2016 | €14,250 | W.E.T. Term Note | — | 3 month EURIBOR | 2.75 |

17

Information related to the fair values of derivative instruments in our consolidated balance sheet as of March 31, 2014 is set forth in Note 6 to the consolidated condensed financial statements included herein.

#### Interest Rate Sensitivity

The table below provides information about the Company’s derivative financial instruments and other financial instruments that are sensitive to changes in interest rates, including interest rate swaps and debt obligations. For debt obligations, the table presents principal cash flows and related weighted average interest rates by expected maturity dates. For interest rate swaps, the table presents notional amounts and weighted average interest rates by expected (contractual) maturity dates. Notional amounts are used to calculate the contractual payments to be exchanged under the contract. Weighted average variable rates are based on implied forward rates in the yield curve at the reporting date. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in U.S. dollars ($USD) or European Euros (€EUR), as indicated in parentheses.

### March 31, 2014

*(In Thousands except rate information)*

| Liabilities Long Term Debt: | Expected Maturity Date 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Fixed Rate (€EUR) | $1,724 | $287 | $— | $— | $— | $— | $— | $2,011 | $2,011 |
| Average Interest Rate | 4.20% | 4.20% |  |  |  |  |  | 4.20% |  |
| Fixed Rate (€EUR) | $— | $1,103 | $1,103 | $1,103 | $1,103 | $1,104 | $— | $5,516 | $5,516 |
| Average Interest Rate |  | 4.25% | 4.25% | 4.25% | 4.25% | 4.25% |  | 4.25% |  |
| Variable Rate ($USD) | $11,538 | $16,956 | $47,937 | $— | $— | $— | $— | $76,431 | $76,431 |
| Average Interest Rate | 2.63% | 2.63% | 2.63% |  |  |  |  | 2.63% |  |
| Variable Rate (€EUR) | $3,096 | $877 | $2,397 | $— | $— | $— | $— | $6,370 | $6,370 |
| Average Interest Rate | 2.34% | 2.34% | 2.34% |  |  |  |  | 2.34% |  |
| Derivative Financial Instruments: |  |  |  |  |  |  |  |  |  |
| Interest Rate Swap ($USD) | $21 | $— | $— | $— | $— | $— | $— | $21 | $21 |
| Average Interest Rate | 0.40% |  |  |  |  |  |  | 0.40% |  |
| Interest Rate Swap ($USD) | $21 | $— | $— | $— | $— | $— | $— | $21 | $21 |
| Average Interest Rate | 0.23% |  |  |  |  |  |  | 0.23% |  |

18

#### Exchange Rate Sensitivity

The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

### March 31, 2014

*(In Thousands except rate information)*

| Anticipated Transactions And Related Derivatives Euro functional currency Forward Exchange Agreements: (Receive HUF/Pay EUR€) | Expected Maturity or Transaction Date 2014 | 2015 | 2016 | 2017 | 2018 | Thereafter | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total Contract Amount (€) | €4,759 |  |  |  |  |  | €4,759 | €(108) |
| Average Contract Rate | 302.61 | — | — | — | — | — | 302.61 |  |
| (Receive CHF/Pay EUR€) |  |  |  |  |  |  |  |  |
| Total Contract Amount (€) | €6,218 | €12,336 | €12,437 | €12,302 | €6,151 |  | €49,444 | €1,332 |
| Average Contract Rate | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | — | 1.20 |  |
| **$US functional currency** |  |  |  |  |  |  |  |  |
| **Forward Exchange Agreements:** |  |  |  |  |  |  |  |  |
| (Receive MXN/Pay USD$) |  |  |  |  |  |  |  |  |
| Total Contract Amount ($) | $12,075 |  |  |  |  |  | $12,075 | $211 |
| Average Contract Rate | 13.416 | — | — | — | — | — | 13.416 |  |

19

## Controls and procedures

As filed, 1,316 characters.

### (a) Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2014, our disclosure controls and procedures were effective to ensure the information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods prescribed by the SEC, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

### (b) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 254 characters.

There were no material changes in our risk factors previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2013. You should carefully consider the risks and uncertainties described therein.

Filed May 9, 2014.
Source: SEC EDGAR, the filing index for accession 0001564590-14-001983. Last ingested by Listed: Oct 26, 2026, 17:44 ET. No prices; not investment advice.
